Tuning the release of the pineal hormone melatonin via poly(ε-caprolactone)-based copolymers matrix tablets

[1]  M. Vlachou,et al.  Modified Release of the Pineal Hormone Melatonin from Matrix Tablets Containing Poly(L-lactic Acid) and Its PLA-co-PEAd and PLA-co-PBAd Copolymers , 2022, Polymers.

[2]  D. Bikiaris,et al.  Poly(Lactic Acid)-Based Microparticles for Drug Delivery Applications: An Overview of Recent Advances , 2022, Pharmaceutics.

[3]  A. Kyritsis,et al.  Molecular mobility, crystallization and melt-memory investigation of molar mass effects on linear and hydroxyl-terminated Poly(ε-caprolactone) , 2022, Polymer.

[4]  V. Karava,et al.  Poly(l-Lactic Acid)-co-poly(Butylene Adipate) New Block Copolymers for the Preparation of Drug-Loaded Long Acting Injectable Microparticles , 2021, Pharmaceutics.

[5]  T. Rades,et al.  Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies , 2021, Pharmaceutics.

[6]  V. Karava,et al.  Block copolymers based on poly(butylene adipate) and poly(L-lactic acid) for biomedical applications: synthesis, structure and thermodynamical studies. , 2021, Soft matter.

[7]  V. Gopinath,et al.  Melatonin delivery from PCL scaffold enhances glycosaminoglycans deposition in human chondrocytes – Bioactive scaffold model for cartilage regeneration , 2020 .

[8]  M. Kostoglou,et al.  Dissolution Enhancement and Controlled Release of Paclitaxel Drug via a Hybrid Nanocarrier Based on mPEG-PCL Amphiphilic Copolymer and Fe-BTC Porous Metal-Organic Framework , 2020, Nanomaterials.

[9]  D. Bikiaris,et al.  Synthesis, crystallization, and molecular mobility in poly(ε-caprolactone) copolyesters of different architectures for biomedical applications studied by calorimetry and dielectric spectroscopy. , 2020, Soft matter.

[10]  N. Ekren,et al.  Encapsulated melatonin in polycaprolactone (PCL) microparticles as a promising graft material. , 2019, Materials science & engineering. C, Materials for biological applications.

[11]  M. Vlachou,et al.  N-Acetylserotonin vs Melatonin: In-Vitro Controlled Release from Hydrophilic Matrix Tablets , 2019, Letters in Drug Design & Discovery.

[12]  G. Guebitz,et al.  Enzymatic Degradation of Star Poly(ε-Caprolactone) with Different Central Units , 2018, Polymers.

[13]  Suhair Sunoqrot,et al.  Correlation between the viscoelastic properties of the gel layer of swollen HPMC matrix tablets and their in vitro drug release , 2018, Pharmaceutical development and technology.

[14]  Waleed Faisal,et al.  Enalapril maleate orally disintegrating tablets: tableting and in vivo evaluation in hypertensive rats , 2018, Pharmaceutical development and technology.

[15]  K. Kim,et al.  Mechanical properties and cytotoxicity of PLA/PCL films , 2018, Biomedical engineering letters.

[16]  A. Tsotinis,et al.  Modified in vitro release of the chronobiotic hormone melatonin from matrix tablets based on the marine sulfated polysaccharide ulvan , 2018 .

[17]  Yaping Zhao,et al.  Preparation of Melatonin-Loaded Zein Nanoparticles using Supercritical CO2 Antisolvent and in vitro Release Evaluation , 2017 .

[18]  M. Vlachou,et al.  Comparative In Vitro Controlled Release Studies on the Chronobiotic Hormone Melatonin from Cyclodextrins-Containing Matrices and Cyclodextrin: Melatonin Complexes , 2017, International journal of molecular sciences.

[19]  Y. Zu,et al.  Melatonin‐loaded silica coated with hydroxypropyl methylcellulose phthalate for enhanced oral bioavailability: Preparation, and in vitro‐in vivo evaluation , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[20]  P. Saini,et al.  Poly(lactic acid) blends in biomedical applications. , 2016, Advanced drug delivery reviews.

[21]  Robert Langer,et al.  Physical and mechanical properties of PLA, and their functions in widespread applications - A comprehensive review. , 2016, Advanced drug delivery reviews.

[22]  M. Gümüşderelioğlu,et al.  Melatonin/HPβCD complex: Microwave synthesis, integration with chitosan scaffolds and inhibitory effects on MG-63CELLS. , 2015, International journal of pharmaceutics.

[23]  M. Kostoglou,et al.  Controlled release formulations of risperidone antipsychotic drug in novel aliphatic polyester carriers: Data analysis and modelling. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[24]  A. Tsotinis,et al.  Controlled Release from Solid Pharmaceutical Formulations of two Nalkanoyl- 4-methoxybicyclo[4.2.0]octa-1,3,5-trien-7-ethanamines with Melatoninergic Activity , 2015 .

[25]  Eric B Kmiec,et al.  Electrospun fiber membranes enable proliferation of genetically modified cells , 2013, International journal of nanomedicine.

[26]  R. Reis,et al.  Performance of biodegradable microcapsules of poly(butylene succinate), poly(butylene succinate-co-adipate) and poly(butylene terephthalate-co-adipate) as drug encapsulation systems. , 2011, Colloids and surfaces. B, Biointerfaces.

[27]  Kinam Park,et al.  Issues in long-term protein delivery using biodegradable microparticles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[28]  K. Chrissafis,et al.  Synthesis, characterization and thermal degradation mechanism of three poly(alkylene adipate)s: Comparative study , 2007 .

[29]  Daniela RUSU,et al.  Poly(vinyl chloride) and Poly(e-caprolactone) Blends for Medical Use , 2006 .

[30]  Philippe Dumas,et al.  FTIR study of polycaprolactone chain organization at interfaces. , 2004, Journal of colloid and interface science.

[31]  Anil Kumar,et al.  Modified release bi-layered tablet of melatonin using beta-cyclodextrin. , 2003, Die Pharmazie.

[32]  G. Regdon,et al.  Quantitative Determination of Crystallinity of α-Lactose Monohydrate by DSC , 2002 .

[33]  P. Costa,et al.  Modeling and comparison of dissolution profiles. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[34]  S. Reppert,et al.  Melatonin receptors step into the light: cloning and classification of subtypes. , 1996, Trends in pharmacological sciences.

[35]  P. Morgan,et al.  Melatonin receptors: Localization, molecular pharmacology and physiological significance , 1994, Neurochemistry International.

[36]  F. Podczeck.  COMPARISON OF IN-VITRO DISSOLUTION PROFILES BY CALCULATING MEAN DISSOLUTION TIME (MDT) OR MEAN RESIDENCE TIME (MRT) , 1993 .

[37]  Alexander G. Dawson,et al.  A double-blind trial of melatonin as a treatment for jet lag in international cabin crew , 1993, Biological Psychiatry.

[38]  G. Maestroni.  The immunoneuroendocrine role of melatonin , 1993, Journal of pineal research.

[39]  S. Folkard,et al.  Some effects of jet-lag and their alleviation by melatonin , 1987 .

[40]  Nicholas A. Peppas,et al.  A simple equation for description of solute release II. Fickian and anomalous release from swellable devices , 1987 .

[41]  K. A. Khan.  The concept of dissolution efficiency , 1975, The Journal of pharmacy and pharmacology.

[42]  T. Higuchi.  MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES. , 1963, Journal of pharmaceutical sciences.

[43]  A. Lerner,et al.  ISOLATION OF MELATONIN, THE PINEAL GLAND FACTOR THAT LIGHTENS MELANOCYTES1 , 1958 .

[44]  M. Mohammadi,et al.  In vitro study of hydroxyapatite/polycaprolactone (HA/PCL) nanocomposite synthesized by an in situ sol-gel process. , 2013, Materials science & engineering. C, Materials for biological applications.